Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.pfizerltd.co.in | |
Market Cap | 19,302.57 Cr. | |
Enterprise Value(EV) | 17,671.74 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 97.32 | Trailing Twelve Months Ending 2022-06 |
Price-Earning Ratio (PE) | 43.36 | Trailing Twelve Months Ending 2022-06 |
Industry PE | 32.02 | Trailing Twelve Months Ending 2022-06 |
Book Value / Share | 633.25 | Trailing Twelve Months Ending 2022-06 |
Price to Book Value | 6.66 | Calculated using Price: 4,219.35 |
Dividend Yield | 0.83 | Period Ending 2022-03 |
No. of Shares Subscribed | 4.57 Cr. | 45,747,732 Shares |
FaceValue | 10 | |
Company Profile | ||
Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products. Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. The company is taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis. |
1 Day |
|
+1.15% |
1 Week |
|
+1.40% |
1 Month |
|
+3.51% |
3 Month |
|
+0.87% |
6 Month |
|
-4.49% |
1 Year |
|
-26.98% |
2 Year |
|
-6.53% |
5 Year |
|
+137.87% |
10 Year |
|
+242.12% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 18.77 | 5.31 | 14.75 | 14.70 | 14.11 | 15.07 | 15.89 | 17.19 | 23.30 | |
Return on Capital Employed (%) | 28.96 | 15.87 | 22.78 | 22.62 | 21.49 | 23.22 | 20.38 | 23.62 | 29.78 | |
Return on Assets (%) | 14.91 | 4.00 | 11.22 | 10.95 | 10.36 | 11.25 | 12.20 | 13.00 | 17.24 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Shh. Funds | 1,694 | 658 | 1,973 | 2,164 | 2,419 | 2,683 | 3,011 | 3,395 | 2,393 | 2,864 | |
Non Curr. Liab. | -26 | -19 | -35 | 66 | 62 | 52 | 37 | 136 | 85 | 136 | |
Curr. Liab. | 351 | 303 | 609 | 658 | 780 | 954 | 892 | 873 | 774 | 853 | |
Minority Int. | |||||||||||
Equity & Liab. | 2,020 | 942 | 2,547 | 2,888 | 3,261 | 3,690 | 3,940 | 4,405 | 3,252 | 3,854 | |
Non Curr. Assets | 215 | 257 | 1,295 | 1,256 | 1,210 | 1,273 | 1,225 | 1,357 | 1,344 | 1,457 | |
Curr. Assets | 1,804 | 686 | 1,252 | 1,632 | 2,051 | 2,417 | 2,715 | 3,048 | 1,908 | 2,396 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2,020 | 942 | 2,547 | 2,888 | 3,261 | 3,690 | 3,940 | 4,405 | 3,252 | 3,854 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-06 Rs. Cr. TTM |
Net Sales | 1,112 | 1,853 | 2,012 | 1,966 | 1,969 | 2,082 | 2,152 | 2,239 | 2,611 | 2,455 | |
Other Income | 109 | 72 | 87 | 101 | 114 | 167 | 184 | 81 | 63 | 68 | |
Total Income | 1,221 | 1,925 | 2,099 | 2,067 | 2,083 | 2,249 | 2,336 | 2,320 | 2,674 | 2,523 | |
Total Expenditure | -873 | -1,474 | -1,579 | -1,616 | -1,468 | -1,516 | -1,579 | -1,526 | -1,775 | -1,713 | |
PBIDT | 349 | 451 | 520 | 451 | 615 | 733 | 757 | 794 | 899 | 810 | |
Interest | -1 | -2 | -1 | -2 | -1 | -2 | -11 | -15 | -11 | -12 | |
Depreciation | -8 | -131 | -58 | -63 | -66 | -71 | -103 | -109 | -115 | -115 | |
Taxation | -119 | -138 | -165 | -180 | -188 | -231 | -133 | -171 | -160 | -102 | |
Exceptional Items | -111 | 10 | 130 | -136 | |||||||
PAT | 221 | 70 | 305 | 337 | 360 | 429 | 509 | 498 | 613 | 445 | |
Adjusted EPS | 74 | 15 | 67 | 74 | 79 | 94 | 111 | 109 | 134 | 97 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -16 | 132 | 113 | 345 | 329 | 332 | 98 | 323 | 427 | 667 | |
Cash Fr. Inv. | 626 | 103 | -89 | -701 | -250 | -238 | 35 | 1,530 | -469 | -575 | |
Cash Fr. Finan. | -43 | -1,360 | -1 | -62 | -83 | -110 | -110 | -164 | -1,571 | -181 | |
Net Change | 567 | -1,125 | 23 | -417 | -3 | -17 | 23 | 1,690 | -1,613 | -88 | |
Cash & Cash Eqvt | 1,433 | 308 | 488 | 71 | 68 | 51 | 74 | 1,764 | 151 | 63 |
Wed, 10 Aug 2022
Announcement under Regulation 30 (LODR)-Resignation of Managing Director Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Company hereby wishes to notify that Mr. S. Sridhar Managing Director has expressed his intention to take an early retirement and has tendered his resignation as the Managing Director of the Company. Mr. Sridhar will continue to serve in his current position of Managing Director for as long a period as required until the identification selection and transition to the new leadership takes place in the Company. The effective date of his resignation shall be as agreed between Mr. Sridhar and the Board of Directors and the same will be notified to you separately.Request you to please take the above on record. |
Fri, 05 Aug 2022
Board Meeting Outcome for Pfizer Limited - Unaudited Financial Results For The Quarter Ended June 30 2022. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the unaudited financial results for the quarter ended June 30 2022 which were approved by the Board of Directors of the Company at its Meeting held today that commenced at 12:00 noon and concluded at 2:45 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP in respect of the above results. |
Fri, 05 Aug 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Registrar and Transfer Agent of the Company KFin Technologies Limited has received a request for issue of duplicate Share Certificate(s) from Shareholder(s) |
Fri, 12 Aug 2022 |
|
|
|
|
|